CA2304349A1 - Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme - Google Patents
Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme Download PDFInfo
- Publication number
- CA2304349A1 CA2304349A1 CA002304349A CA2304349A CA2304349A1 CA 2304349 A1 CA2304349 A1 CA 2304349A1 CA 002304349 A CA002304349 A CA 002304349A CA 2304349 A CA2304349 A CA 2304349A CA 2304349 A1 CA2304349 A1 CA 2304349A1
- Authority
- CA
- Canada
- Prior art keywords
- alleles
- pigs
- fabp
- pig
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 45
- 108700028369 Alleles Proteins 0.000 title claims abstract description 42
- 241001465754 Metazoa Species 0.000 title abstract description 44
- 101001062864 Homo sapiens Fatty acid-binding protein, adipocyte Proteins 0.000 title description 42
- 102100030431 Fatty acid-binding protein, adipocyte Human genes 0.000 title description 23
- 241000282887 Suidae Species 0.000 claims abstract description 25
- 238000009395 breeding Methods 0.000 claims abstract description 16
- 230000001488 breeding effect Effects 0.000 claims abstract description 15
- 101001062859 Sus scrofa Fatty acid-binding protein, adipocyte Proteins 0.000 claims abstract description 13
- 230000003321 amplification Effects 0.000 claims abstract description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 239000012634 fragment Substances 0.000 claims description 19
- 230000037396 body weight Effects 0.000 claims description 14
- 108091092878 Microsatellite Proteins 0.000 claims description 13
- 239000003550 marker Substances 0.000 claims description 9
- 238000007918 intramuscular administration Methods 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 3
- 239000012472 biological sample Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 claims description 3
- 230000004083 survival effect Effects 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 2
- 230000004807 localization Effects 0.000 claims description 2
- 210000001161 mammalian embryo Anatomy 0.000 claims description 2
- 101710118908 Fatty acid-binding protein, adipocyte Proteins 0.000 claims 4
- 238000003752 polymerase chain reaction Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 2
- 241000282898 Sus scrofa Species 0.000 description 18
- 235000013372 meat Nutrition 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 description 10
- 230000007614 genetic variation Effects 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 101100226596 Gallus gallus FABP gene Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 7
- 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 108091022862 fatty acid binding Proteins 0.000 description 5
- 235000020997 lean meat Nutrition 0.000 description 5
- 238000003307 slaughter Methods 0.000 description 5
- 230000002596 correlated effect Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 101001062862 Mus musculus Fatty acid-binding protein, adipocyte Proteins 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 230000014107 chromosome localization Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 2
- 102000000476 Fatty Acid Transport Proteins Human genes 0.000 description 2
- 108010055870 Fatty Acid Transport Proteins Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000012098 association analyses Methods 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 2
- 210000004754 hybrid cell Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000000304 Intracellular lipid binding proteins Human genes 0.000 description 1
- 108050008756 Intracellular lipid binding proteins Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000757120 Mecolaesthus longissimus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000043365 Myelin P2 Human genes 0.000 description 1
- 101710200598 Myelin P2 protein Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 235000021052 average daily weight gain Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000009753 muscle formation Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention porte sur une nouvelle séquence du gène A-FABP du porc, ainsi que sur des procédés d'utilisation de ce gène et de ses produits. L'invention porte notamment sur des procédés de détection de différents allèles du gène A-FABP du porc qui sont associés à des différences de caractères génotypiques et/ou phénotypiques des porcs possédant ces allèles. L'invention porte encore sur des procédés permettant de faire une distinction entre des allèles issus de différents phénotypes, notamment à l'aide de techniques consistant à réaliser une amplification sélective de matériaux dérivés du gène A-FABP du porc. Ces techniques sont particulièrement adaptées pour sélectionner des animaux destinés à être utilisés dans des programmes d'amélioration génétique. L'invention porte également sur des programmes d'amélioration génétique utilisant ces techniques.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202857 | 1997-09-18 | ||
| EP97202857.5 | 1997-09-18 | ||
| PCT/NL1998/000541 WO1999014365A1 (fr) | 1997-09-18 | 1998-09-18 | Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2304349A1 true CA2304349A1 (fr) | 1999-03-25 |
Family
ID=8228733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002304349A Abandoned CA2304349A1 (fr) | 1997-09-18 | 1998-09-18 | Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1015634A1 (fr) |
| AU (1) | AU9189998A (fr) |
| CA (1) | CA2304349A1 (fr) |
| WO (1) | WO1999014365A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1111043A1 (fr) * | 1999-12-21 | 2001-06-27 | Institute for Pig Genetics B.V. | Nouveaux QTL sur les chromosomes X, 2, 6 et 7 de cochons |
| US20070234437A1 (en) * | 2006-03-16 | 2007-10-04 | Hasan Khatib | Detection of Lethality Gene for Improved Fertility in Mammals |
| CN101935706B (zh) * | 2010-09-02 | 2012-05-30 | 中国农业科学院北京畜牧兽医研究所 | 一种检测猪肉品质性状的方法及专用引物对 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006104A1 (fr) * | 1990-09-28 | 1992-04-16 | The Dana-Farber Cancer Institute | Sequences d'adn specifiques aux adipocytes et leur utilisation dans la production d'animaux transgeniques presentant un metabolisme des graisses modifie |
| DE4338817A1 (de) * | 1993-11-13 | 1995-06-14 | Max Delbrueck Centrum | Gensequenzen von Cellular X Binding Proteinen |
| WO1997035878A2 (fr) * | 1996-03-28 | 1997-10-02 | Pig Genes B.V. I.O. | Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps |
-
1998
- 1998-09-18 CA CA002304349A patent/CA2304349A1/fr not_active Abandoned
- 1998-09-18 EP EP98944340A patent/EP1015634A1/fr not_active Withdrawn
- 1998-09-18 WO PCT/NL1998/000541 patent/WO1999014365A1/fr not_active Ceased
- 1998-09-18 AU AU91899/98A patent/AU9189998A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1015634A1 (fr) | 2000-07-05 |
| WO1999014365A1 (fr) | 1999-03-25 |
| AU9189998A (en) | 1999-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gerbens et al. | The adipocyte fatty acid-binding protein locus: characterization and association with intramuscular fat content in pigs | |
| Ciobanu et al. | Genetic variation in two conserved local Romanian pig breeds using type 1 DNA markers | |
| EP1141418B1 (fr) | Selection d'animaux en fonction de traits communiques par leurs parents | |
| HUP0300141A2 (en) | Genetic markers for improved meat characteristics in animals | |
| AU5011600A (en) | Genetic marker for meat quality, growth, carcass and reproductive traits in livestock | |
| EP1437418B1 (fr) | Sélection d'animaux ayant des propriétés génotypiques ou potentiellement phénotypiques, basée sur un polymorphisme de nucléotide somple (SNP) dans l'intron 3 du gène de IGF2 | |
| MXPA04008989A (es) | Alelos hmga novedosos y usos de los mismos como marcadores geneticos para el crecimiento, gordura, calidad de la carne y caracteristicas de eficiencia alimenticia. | |
| CN116590433B (zh) | 大白母猪繁殖性能的分子标记、引物、试剂盒、鉴定方法及应用 | |
| AU725544B2 (en) | The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight | |
| CA2290768C (fr) | Methodes et compositions d'identification des porcs genetiquement receptifs a des maladies associees au f18 e. coli | |
| Nowacka-Woszuk et al. | Chromosomal localization of 13 candidate genes for human obesity in the pig genome | |
| CA2304349A1 (fr) | Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme | |
| EP0868533A1 (fr) | Gene de la myogenine du porc et procede d'identification de polymorphismes lies au developpement musculaire | |
| KR101149696B1 (ko) | 지방산 합성효소의 유전자형을 토대로 소 근육내 지방에 있어서의 지방산 함유량의 많고 적음을 판정하는 방법 및 그 결과를 토대로 쇠고기의 식미의 좋음을 판정하는 방법 | |
| KR20220159020A (ko) | 난축맛돈 돼지육 판별용 조성물 및 이의 용도 | |
| EP1660675B1 (fr) | Polymorphisme de l'igf2 et ame lioration des caracteristiques de production des bovins | |
| US7157231B2 (en) | Method of evaluating useful cattle | |
| KR20080006719A (ko) | 소 근내지방도 관련 ｆａｂｐ4 유전자를 이용한 ｄｎａ마커 | |
| AU2003226666B2 (en) | Method for identifying animals for milk production qualities by analyzing the polymorphism of the PIT-1 and kappa-casein genes | |
| FRAJMAN et al. | Milk production in the post-genomic era | |
| WO2007068936A2 (fr) | Méthode de diagnostic | |
| CN117947176A (zh) | 一种评估中国西门塔尔牛的牛肉品质性状的方法 | |
| Hansen | Evaluating six positional candidate genes for effects on meat tenderness | |
| Campbell | Identification and isolation of genes affecting adipose tissue development | |
| Törnsten | Physical mapping of important trait loci in the pig |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |